Environmental risk caused by drug waste in the city of Rio de Janeiro, Brazil, during the SARS-Covl9 pandemic

• Published in: Ciência & saude coletiva 2023-03, Vol.28 (3), p.711
• Main Authors: de Souza, Carla Patricia Figueiredo Antunes, Kligerman, Debora Cynamon, Bezerra, Giselle Mendes, da Mota Oliveira, Jaime Lopes
• Format: Article
• Language: eng ; por
• Subjects: Antidepressants; Dexchlorpheniramine; Drugs; Epidemics; Ethinyl estradiol; Health aspects; Influenza
• ISSN: 1413-8123
• DOI: 10.1590/1413-81232023283.05722022EN

The relationship between the distribution of medicines used in the Pandemic by SARS-COV-19 in the municipality of Rio de Janeiro and the estimated level of environmental risk caused by their residues was evaluated. The amount of medicines distributed by primary health care (PHC) units between 2019 and 2021 were collected. The risk quotient (RQ) corresponded to the ratio between the estimated predictive environmental concentration (PECest) obtained by the consumption and excretion of each drug and its non-effective predictive concentration (PNEC). Between 2019 and 2020, the PECest of azithromycin (AZI) and ivermectin (WE) increased between 2019 and 2020, with a decrease in 2021 probably due to shortages. Dexchlorpheniramine (DEX) and fluoxetine (FLU) fell, returning to growth in 2021. While the PECest of diazepam (DIA) increased over these 3 years, ethinylestradiol (EE2) decreased possibly due to the prioritization of PHC in the treatment of COVID-19. The largest QR were from FLU, EE2 and AZI. The consumption pattern of these drugs did not reflect their environmental risk because the most consumed ones have low toxicity. It is worth noting that some data may be underestimated due to the incentive given during the pandemic to the consumption of certain groups of drugs.